Skip to main content
Log in

Accuracy of Determining Nodal Negativity in Colorectal Cancer on the Basis of the Number of Nodes Retrieved on Resection

Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background: Correct determination of nodal status is pivotal to accurate staging and predicting survival.

Methods: This is a secondary analysis of INT0089, an intergroup trial of adjuvant chemotherapy for high-risk stage II and III colon cancer. A subset of patients was studied who underwent right or left hemicolectomy and from whom at least 10 lymph nodes were examined. A mathematical model was created to estimate the probability of a true negative result on the basis of the number of nodes examined. The number of nodes needed to predict nodal negativity with 85%, 50%, and 25% probability on the basis of tumor stage was calculated.

Results: In this analysis, 1585 patients were studied. The average number of nodes removed at surgery was comparable between treatment groups at 18.5 (median of 16 in all groups). With this model, when 18 nodes are removed at resection, there is a <25% probability of true node negativity in T1/T2 tumors, whereas <10 nodes need to be examined in T3 and T4 tumors to achieve the same probability.

Conclusions: Tumor stage and the number of nodes retrieved at resection influence the accuracy of determining nodal status in colon cancer. Most patients are understaged. Underestimating nodal stage may influence decisions regarding adjuvant therapy, as well as overall prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. Hermanek P. pTNM and residual tumor classifications: problems of assessment and prognostic significance. World J Surg 1995; 19: 184–90.

    Google Scholar 

  2. Moertel CG. Chemotherapy for colorectal cancer. N Engl J Med 1994; 330: 1136–42.

    Article  CAS  PubMed  Google Scholar 

  3. O’Connell MJ. North Central Cancer Treatment Group—Mayo Clinic trials in colon cancer. Semin Oncol 2001; 28: 4–8.

    Google Scholar 

  4. O’Connell MJ, Maillard JA, Kahn MJ, et al. Controlled trial of fluorouracil and low dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol 1997; 15: 246–50.

    CAS  PubMed  Google Scholar 

  5. Hernanz F, Revuelta S, Redondo C, et al. Colorectal adenocarcinoma: quality of the assessment of lymph node metastases. Dis Colon Rectum 1994; 37: 373–7.

    CAS  PubMed  Google Scholar 

  6. Goldstein NS, Sanford W, Coffey M, Layfield LJ. Lymph node recovery from colorectal resection specimens removed for adenocarcinoma: trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol 1996; 106: 209–16.

    CAS  PubMed  Google Scholar 

  7. Wong JH, Severino R, Honnebier MB, Tom P, Namiki TS. Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol 1999; 17: 2896–900.

    Google Scholar 

  8. Reinbach DH, McGregor JR, Murray GD, O’Dwyer PJ. Effect of the surgeon’s specialty interest on the type of resection performed for colorectal cancer. Dis Colon Rectum 1994; 37: 1020–3.

    CAS  PubMed  Google Scholar 

  9. Scott KWM, Grace RH. Detection of lymph node metastases in colorectal carcinoma before and after fat clearance. Br J Surg 1989; 76: 1165–7.

    Google Scholar 

  10. Kiricuta CI, Tausch J. A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma. Cancer 1992; 69: 2496–501.

    Google Scholar 

  11. Herrera-Ornelas L. Metastases in small lymph nodes from colon cancer. Arch Surg 1987; 122: 1253–6.

    CAS  PubMed  Google Scholar 

  12. Cohen AM, Kelsen D, Saltz L, et al. Adjuvant therapy for colorectal cancer. Curr Probl Cancer 1998; 22: 5–65.

    Google Scholar 

  13. Liefers G, Cleton-Jansen A, van de Velde CJ, et al. Micrometastases and survival in stage II colorectal cancer. N Engl J Med 1998; 339: 223–8.

    Article  CAS  PubMed  Google Scholar 

  14. Giacomantonia CA, Temple WJ. Quality of cancer surgery: challenges and controversies. Surg Oncol Clin North Am 2000; 9: 51–60.

    Google Scholar 

  15. Saettler EB, Temple WJ. The surgeon as a prognostic factor in the management of pancreatic cancer. Surg Oncol Clin North Am 2000; 9: 133–42.

    Google Scholar 

  16. Hartgrink HH, Bonenkamp HJ, van de Velde CJH. Influences of surgery on outcomes in gastric cancer. Surg Oncol Clin North Am 2000; 9: 97–117.

    Google Scholar 

  17. Hida J, Mori N, Kubo R, et al. Metastases from carcinoma of the colon and rectum detected in small lymph nodes by the clearing method. J Am Coll Surg 1994; 178: 223–8.

    CAS  PubMed  Google Scholar 

  18. Rodriguez-Bigas MA, Maamoun S, Weber TK, et al. Clinical significance of colorectal cancer: metastases in lymph nodes <5 mm in size. Ann Surg Oncol 1996; 3: 124–30.

    CAS  PubMed  Google Scholar 

  19. Le Voyer TE, Sigurdson ER, Hanlon AL, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed. A secondary survey of INT-0089 (abstract). Proc Am Soc Clin Oncol 2000; 925.

  20. Tepper JE, O’Connell MJ, Niedzwiecki D, et al. Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol 2001; 19: 157–63.

    Google Scholar 

  21. Esser S, Reilly WT, Riley LB, et al. The role of sentinel lymph node mapping in staging of colon and rectal cancer. Dis Colon Rectum 2001; 44: 850–6.

    CAS  PubMed  Google Scholar 

  22. Paramo JC, Summerall J, Wilson C, et al. Intraoperative sentinel lymph node mapping in patients with colon cancer. Am J Surg 2001; 182: 40–3.

    Google Scholar 

  23. Bendavid Y, Latulippe JF, Younan RJ, et al. Phase I study on sentinel lymph node mapping in colon cancer: a preliminary report. J Surg Oncol 2002; 79: 81–4.

    PubMed  Google Scholar 

  24. Tsioulias GJ, Wood TF, Morton DL, et al. Lymphatic mapping and focused analysis of sentinel lymph nodes upstage gastrointestinal neoplasms. Arch Surg 2000; 135: 926–32.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Elin R. Sigurdson MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Joseph, N.E., Sigurdson, E.R., Hanlon, A.L. et al. Accuracy of Determining Nodal Negativity in Colorectal Cancer on the Basis of the Number of Nodes Retrieved on Resection. Ann Surg Oncol 10, 213–218 (2003). https://doi.org/10.1245/ASO.2003.03.059

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1245/ASO.2003.03.059

Key Words

Navigation